Brown, A., Deacon, B., Abramowitz, J., Dammann, J., & Whiteside, S. (2007). Parents’ perception of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. Behavior Research and Therapy, 45, 819–828.
Byrne, S.P., Farrell, L.J., Storch, E., & Rapee, R.M. (2014). D-cycloserine augmented treatment of anxiety disorders in children and adolescents: A review of preliminary research. Psychopathology Review, 1, 157–168.
Byrne, S., Rapee, R., Malhi, G., Richardson, R., Jones, M., & Hudson, J. (2015). D-cycloserine enhances generalization of fear extinction in children. Depression and Anxiety, 32, 408–414.
Chavira, D., Stein, M., Bailey, K., & Stein, M. (2003). Parental opinions regarding treatment for social anxiety disorder in youth. Journal of Developmental and Behavioral Pediatrics, 24, 315–322.
Creamer, M., Foran, J., & Bell, R. (1995). The Beck Anxiety Inventory in a non-clinical sample. Behavior Research and Therapy, 33, 477–485.
Cross-Calvert, S., & Johnston, C. (1990). Acceptability of treatments for child behavior problems: Issues and implications for future research. Journal of Clinical Child Psychololgy, 19, 61–74.
Deacon, B.J., & Abramowitz, J.S. (2005). Patients’ perceptions of pharmacological and cognitive-behavioral treatments for anxiety disorders. Behavior Therapy, 36, 139–145.
Farrell, L.J., Waters, A.M., Boschen, M.J., Hattingh, L., McConnell, H., Milliner, E.L., . . . Storch, E.A. (2013). Difficult to treat pediatric obsessive compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-Cycloserine augmented behavior therapy, Depression and Anxiety, 30, 723–731.
Gage, & Wilson, (2000). Acceptability of attention deficit hyperactivity disorder: A comparison of parents. Journal of Attention Disorders, 4, 178–182.
Hofmann, S.G. (2014). D-cycloserine for treating anxiety disorders: Making good exposures better and bad exposures worse. Depression and Anxiety, 31, 175–177.
Hong, S., & Shepherd, M. (1996). Psychosocial and demographic predictors of pediatric psychotropic medication use. American Journal of Health Systems Pharmacy, 53, 1934–1939.
Hatzimanolis, I., & Alevizos, V. (1999). Attitudes and opinion of non-psychiatric physicians and a general population sample about psychotropic drugs. Psychiatry, 10, 135–141.
Johnston, C., Hommersen, P., & Seipp, C. (2008). Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: Relations to child and and parent characteristics. Behavior Therapy, 39, 22–32.
Kazdin, A.E. (1980). Acceptability of alternative treatments for deviant child behavior. Journal of Applied Behavioral Analysis, 13, 259–273.
Lazaratou, H., Anagnostopoulos, D., Alevizos, E., Haviara, F., & Ploumpidis, D. (2007). Parental attitudes and opinions on the use of psychotropic medications in mental disorders of childhood. Annals of General Psychiatry, 6, 32–38.
Mertens, D. (2005). Research and evaluation in education and psychology: Integrating diversity with quantitative, qualitative, and mixed methods. Thousand Oaks, CA: Sage Publications.
McLeod, J., Pescosolido, B., Takeuchi, D., & White, F. (2004). Public attitudes toward the use of psychiatric medications for children. Journal of Health and Human Behavior
Monastra, V. (2005). Overcoming barriers to effective treatment for attention-deficit/hyperactivity disorder: A neuro-educational approach. International Journal Psychophysiology, 58, 71–80.
Norberg, M.M., Krystal, J.H., & Tolin, D.F. (2008). A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118–1126.
Rapee, R.M., Schniering, C.A., & Hudson, J.L. (2009). Anxiety disorders during childhood and adolescence: Origins and treatment. Annual Review of Clinical Psychology, 5, 311–341.
Rappaport, N., & Chubinsky, P. (2000). The meaning of psychotropic medications for children, adolescents and their families. Journal of American Academy of Child and Adolescent Psychiatry, 39, 1198–1200.
Roberts, C., Farrell, L.J., Waters, A.M., Oar, E. & Ollendick, T.H. (2016) Parents’ perceptions of novel treatments for child and adolescent specific phobia and anxiety disorders. Child Psychiatry and Human Devevelopment, 47, 459–471.
Spielberger, C. (1983). Manual for the State Trait Anxiety Inventory — STAI (Form Y). Palo Alto, CA: Mind Garden.
Storch, E.A., McKay, D., Reid, J.M., Geller, D.A., Goodman, W.K., Lewin, A.B., & Murphy, T.K. (2010). D-cycloserine augmentation of cognitive-behavioral therapy: Directions for pilot research in pediatric obsessive-compulsive disorder. Child Youth Care Forum, 39, 101–112.
Whalen, C.K., & Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. Journal of Consulting and Clinical Psychology, 59, 126–137.